Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Promis Neurosciences (PMN) had Weighted-Average Shares Outstanding (Diluted) of 26.46M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$2.78M |
|
-- |
|
-- |
|
$16.83M |
|
$-16.83M |
|
$19.61M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$-16.83M |
|
$-16.83M |
|
25.92M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
26.46M |
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$18.91M |
|
-- |
|
-- |
|
$18.91M |
|
$2.22M |
|
-- |
|
$0.20M |
|
$2.42M |
|
$16.49M |
|
$16.49M |
|
$16.49M |
|
32.69M |
|
| Cash Flow Statement Financials | |
$-27.18M |
|
$-0.00M |
|
$27.88M |
|
$12.60M |
|
$13.29M |
|
$0.69M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
16.85% |
|
16.85% |
|
14.69% |
|
16.85% |
|
$0.50 |
|
$-1.03 |
|
$-1.03 |
|